SL Science Holding Ltd
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata…
1D
-1.3%
1W
+1.3%
1M
-15.5%
6M
–
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
P/E
0
P/B
0
EV/EBITDA
-228.89
RETURN ON EQUITY
0.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.09
DIVIDEND YIELD
0.0%
AS OF
31/12/2025
FREE FLOAT
40.5%
FLOAT SHARES
226,907,516
AVG. DAILY VOLUME (30D)
89,107
Wang Ching-Dong
SL Science Holding Ltd is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is William Wang, the company employs around 15 people.
The IPO was on 05/02/2025; the stock trades on NASDAQ under the ticker SLBT.
No, SL Science Holding currently does not pay a dividend.
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
Clicking "Analyze stock" lets five strategies assess SL Science Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.